Adimmune Corp (4142)

Taiwan
57.60
-5.30(-8.43%)
  • Volume:
    83,917,000
  • Bid/Ask:
    57.50/57.60
  • Day's Range:
    56.70 - 64.80

4142 Overview

Prev. Close
62.9
Day's Range
56.7 - 64.8
Revenue
1.87B
Open
61.1
52 wk Range
42.05 - 79.8
EPS
2.84
Volume
83,917,000
Market Cap
27.02B
Dividend (Yield)
0.50 (N/A)
Average Vol. (3m)
15,609,366
P/E Ratio
22.14
Beta
0.07
1-Year Change
50.84%
Shares Outstanding
429,508,000
Next Earnings Date
Jun 02, 2021
What is your sentiment on Adimmune Corp?
or
Market is currently closed. Voting is open during market hours.

Adimmune Corp News

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellSellNeutralStrong BuyStrong Buy
Technical IndicatorsStrong SellStrong SellSellStrong BuyBuy
SummaryStrong SellStrong SellNeutralStrong BuyStrong Buy

Adimmune Corp Company Profile

Adimmune Corp Company Profile

Employees
503
Market
Taiwan

ADIMMUNE CORPORATION is a Taiwan-based company principally engaged in the research and development, processing, manufacture and trading of influenza vaccine products and non-flu vaccine products. The Company's products include Japanese encephalitis vaccines, tetanus vaccines, influenza vaccines, H1N1 influenza vaccines and tuberculin. The vaccine products are applied in the prevention of various infectious viruses. The tuberculin is applied in tuberculin purified protein derivative (PPD) test. The Company distributes its products within domestic market and to overseas markets, including other markets in Asia, Europe and Africa.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.